MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$119,437K
Marketable securities
$371,066K
Prepaid expenses and
other current assets
$5,119K
Operating lease
right-of-use assets
$564K
Other long-term
assets
$7,239K
Total current assets
$495,622K
Property and equipment,
net
$462K
Total assets
$503,887K
Total liabilities and
stockholders' equity
$503,887K
Total stockholders'
equity
$488,472K
Total liabilities
$15,415K
Accumulated other
comprehensive (loss) income
-$177K
Accumulated deficit
-$297,351K
Additional paid-in capital
$785,941K
Long-term liabilities
$204K
Total current
liabilities
$15,211K
Common stock, par value
0.001 authorized...
$59K
Accounts payable
$2,351K
Accrued expenses and
other current...
$12,860K
Back
Back
Balance Sheet
source: myfinsight.com
Enliven Therapeutics, Inc. (IMRA)
Enliven Therapeutics, Inc. (IMRA)